epoetin alfa,luspatercept
bms
['lusp', 'epoetin']
 patients who received luspatercept were significantly more likely to experience freedom from transfusions of red blood cells than those who received epoetin alfa," explained #asco23 speaker guillermo garcia-manero, md. 
Reporting essential clinical news w/ independent analysis for cancer care professionals to optimize patient care & outcomes; oncology/hematology